Blødning (mest hæmatom) var som forventet almindelig i denne patientpopulation, hvor en stor del af patienterne samtidig tog antikoagulationsmedicin.
Bleeding events (mostly haematoma) were common as expected in this patient population with a high proportion of patients taking anticoagulant co-medication.